Treatment effectiveness can have different meanings to patients,” a physician assistant said when discussing therapy for high ...

Patients with breast cancer who are of childbearing age may face issues that are accentuated by their age, an expert ...

A nurse practitioner discussed considerations for managing aromatase inhibitor-related joint pain in patients with breast ...

A poll of experts revealed that few are utilizing talquetamab for patients with pretreated relapsed/refractory myeloma.

The FDA granted a priority review to acalabrutinib for the treatment of previously untreated adults with mantle cell lymphoma ...

Extensive-stage (stage IV) SCLC, on the other hand, is a disease that has spread outside the bounds of 1 radiation field, and ...

As biomarkers continue to be explored in resectable melanoma, oncology nurses will play a crucial role in the clinical trial ...

After a patient with estrogen receptor (ER)-positive, HER2-negative metastatic breast cancer experiences disease progression ...

Oral drugs in the HR-positive, HER2-negative metastatic breast cancer space put a focus on clear patient-provider ...

The FDA approved zolbetuximab-clzb plus fluoropyrimidine- and platinum-containing chemotherapy for patients with CLDN18.2-positive locally advanced unresectable or metastatic HER2-negative gastric or ...

An expert explained the role oncology nurses and advanced practice providers play in caring for patients with sarcoma during treatment.

Providers should consider lifestyle preferences and other conditions/comorbidities before deciding between bispecific antibodies or CAR T-cell therapy in myeloma. Lifestyle preferences and baseline ...